Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

EQT to acquire majority interest in Aldevron – the leading global supplier of plasmid DNA used in cell and gene therapies

· EQT to partner with founder and CEO Michael Chambers, as well as TA Associates, to support Aldevron on its future growth journey · EQT will support Aldevron through investments in additional production capacity, R&D, and growth initiatives and by leveraging EQT’s strong healthcare expertise, global presence, and network of Industrial Advisors New York, NY - July 31, 2019 - The EQT VIII Fund (“EQT” or “EQT VIII”) today announced that it has entered into an agreement to acquire a majority interest in Aldevron (the “Company”). Following the close of the transaction, EQT VIII will own

Ten years since first order of RayStation treatment planning system

This summer marks the ten-year anniversary since the first order of the treatment planning system RayStation. The first customer was the proton center Westdeutsches Protonentherapie-zentrum Essen (WPE) in Germany. Ten years later, RayStation is established at 580 clinics all over the world, of which 55 are particle therapy centers.RaySearch has been developing world-class software since 2000, at first selling advanced calculation modules to other vendors. After a few years in practice, RaySearch decided to develop its own treatment planning system, named RayStation. In June 2009, it was

Number of shares and votes in Oncopeptides

Stockholm — 31 July 2019 — Oncopeptides AB (Nasdaq Stockholm, ONCO) today announces that the number of shares and votes in Oncopeptides has changed as a result of the issue of 5,015,000 shares, which was carried out 28 June 2019, and registered by the Swedish Companies Registration Office in July 2019The share issue entails a dilution of approximately 9.3 percent of the number of shares and votes in the company. Through the issue, the number of outstanding shares and votes increases by 5,015,000 from 48,841,921 to 53,856,921. The share capital will increase by approximately SEK 557,222 from

Press release: Funcom has released Seed of Evil, expansion for Mutant Year Zero: Road to Eden

In today's press release publisher Funcom and developer The Bearded Ladies announce that Seed of Evil, the expansion to the tactical adventure game Mutant Year Zero: Road to Eden has released digitally on PC (Steam) and Xbox One, with PlayStation 4 soon to follow. Also, the game has released for the first time digitally on Nintendo Switch in a Deluxe Edition featuring the original game and the expansion. The Deluxe Edition is also available digitally for PC (Steam), Xbox One and soon to follow PlayStation 4. Furthermore, the game has also officially released in retail

Changed Number of Shares and Votes in SEMAFO

Montreal, Quebec, July 31, 2019 /CNW/ – SEMAFO (TSX, OMX: SMF) reports the following, in accordance with the Swedish Financial Instruments Trading Act: As a result of the exercise of stock options and warrants, including in connection with the acquisition of Savary Gold Corp., the number of issued and outstanding shares of SEMAFO has increased from 333,979,993 to 334,435,433 common shares with voting rights as at July 31, 2019. The information in this release is subject to the disclosure requirements of SEMAFO under the Swedish Securities Market Act and/or the Swedish Financial

INTERIM REPORT for Bergs Timber AB (publ) 1 January 2019 – 30 June 2019

Second quarter (1 April – 30 June) · Net sales for the second quarter 2019 amounted to SEK 913 (711) million. The increase relates to the acquisition of the Norvik operations in the Baltic States and the UK that was completed in May 2018. · Operating profit amounted to SEK 38 (55) million, representing an operating margin of 4.2 (7.7) percent. Adjusted for income from negative excess value and transaction costs related to the acquisition of Fågelfors Hyvleri, the operating profit was SEK 27 million. · Profit after tax was SEK 28 (42) million. Earnings per share, before and

Increased number of shares and votes

On July 9, 2019, part of the convertible 1707 was converted. The convertible bond were issued in July 2017 in connection with the acquisition of MV Nordic AS. With the conversion has the number of B-shares increased by 29 875 and the share capital increased by 2 987.50 SEK. The total number of shares after conversion amounts to 32,368,775 of which 3,350,000 are A-shares. A-shares have10 votes and B shares one vote.For more information, please contact Patrik Fransson, Investor Relations patrik.fransson@vitec.se +46-76-9428597 Disclaimer This information is of such a kind

Neste Rally Finland features the sweetest trick of the summer to promote circular economy

Neste Corporation, News, 31 July 2019 at 2.00pm (EET) Neste Rally Finland, part of the World Rally Championship hosted by FIA, brings the world’s top rally drivers and co-drivers to Central Finland on 1.-4.8.2019. This year AKK, the organizer of Neste Rally Finland, continues to refuel its diesel cars during the rally with Neste MY Renewable Diesel, and the fuel is also used to produce electricity at Neste MY Arena in Leustu, Finland.  Neste also offers a great chance to explore the opportunities of circular economy at Neste Rally Finland, which is one of the biggest annual

SECURITAS AB INTERIM REPORT January–June 2019

APRIL–JUNE 2019• Total sales MSEK 27 684 (25 466)• Organic sales growth 5 percent (7)• Operating income before amortization MSEK 1 377 (1 286)• Operating margin 5.0 percent (5.0)• Items affecting comparability (IAC) MSEK –46 (0), relating to IS/IT transformation programs• Earnings per share SEK 2.18 (2.28)• Earnings per share, before IAC, SEK 2.27 (2.28) JANUARY–JUNE 2019• Total sales MSEK 54 428 (48 822)• Organic sales growth 6 percent (7)• Operating income before amortization MSEK 2 667 (2 377)• Operating margin 4.9 percent (4.9)• Items affecting comparability (

Change in the number of shares and votes in Endomines

Endomines AB, Stock Exchange Release 31 July 2019, at 12:00 CEST The total number of shares and votes in Endomines AB (publ) ("Endomines" or the "Company") amounts to 79,957,043 as at 31 July 2019. The number of shares and votes in the Company has increased by 44,549,555 during the month of July following the rights issue previously informed of. In connection with the rights issue, a bonus issue and reduction of the share capital have also been carried out in accordance with resolutions at the Company's Annual General Meeting. Following the above-mentioned measures, Endomines share

New Konecranes retrofit helps customers connect to even more of their crane fleet

Konecranes today launched a TRUCONNECT® retrofit  which brings the industry’s leading real-time, data-driven remote monitoring to owners of Demag cranes. The retrofit equips Demag DMR SafeControl equipped hoists and cranes with the hardware needed for Konecranes TRUCONNECT Remote Monitoring , with the resulting data available for analysis on the Konecranes customer portal yourKONECRANES.com.

Conversion of shares in NCC AB

According to NCC’s articles of association, owners of Series A shares are entitled to request that such shares be converted to Series B shares. Conversion reduces the total number of voting rights in the company.During July 2019, 52,202 Series A shares were converted to Series B shares at the request of shareholders, following which the total number of voting rights in the company amounts to 228,007,059. The total number of registered shares in the company amount to 108,435,822, of which 13,285,693 are Series A and 95,150,129 are Series B. NCC holds 530,267 Series B shares in treasury.

Change in number of shares and votes in Episurf Medical

Episurf Medical AB (NASDAQ: EPIS B) has, by information previously announced, conducted a new issue of shares with preferential rights for the company's shareholders. Through the new issue, the number of shares has increased by 478,147 A-shares and 53,251,966 B-shares and the number of votes has increased by 54,686,407. The total number of shares amounts to 90,930,755, of which 971,024 are A shares and 89,959,731 are B shares. The total number of votes after the conversions amounts to 92,872,803. The share capital has increased by SEK 16,132,677.74 and now amounts to SEK 27,302,316.80.

New number of votes in Bonava AB due to conversion

The number of shares and votes in Bonava AB has changed due to conversions of a total of 1,000,000 shares of series A to a total of 1,000,000 shares of series B.According to Bonava’s articles of association, owner of a share of series A has the right to request that such share is converted to a share of series B. In July 2019, 1,000,000 shares of series A were converted to 1,000,000 shares of series B at the request of shareholders. Following the conversions, there were, as of July 31, 2019, the last trading day of the month, a total of 108,435,822 registered shares in Bonava AB. Of

Number of shares and votes in Medicover

The number of votes in Medicover AB (publ) (“Medicover ”) has changed as a result of conversions of in total 16,735 class A shares into class B shares carried out in July following requests from shareholders in accordance with the conversion clause in Medicover’s articles of association. Today, the last trading day of the month, there are in total 135,735,195 shares in Medicover, of which 78,803,616 are class A shares, together carrying 78,803,616 votes, 54,531,579 are class B shares, together carrying 5,453,157.90 votes and 2,400,000 are class C shares,

There are no items matching the current filter
There are no more items matching the current filter
Back to top